Cystic Fibrosis Buyers Club Shows the UK Government The Way
The move by a group of parents of children with cystic fibrosis (CF) to set up a buyers club to gain access to treatments...
Urgent collective action to meet the challenge of this pandemic crisis: a coronavirus related...
The Director-General of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, first described the present coronavirus (COVID-19) outbreak as a pandemic on the 11th...
Medicines Law & Policy’s director, Ellen ’t Hoen, receives high Netherlands honour for her...
Ellen 't Hoen has been appointed Officer of the Order of Oranje-Nassau, a royal award which recognises those who merit particular appreciation from society...
“The diseases were in the South and the drugs were in the North”: Ellen...
Ellen 't Hoen discusses the HIV epidemic in the 90's, which hit sub-Saharan Africa particularly hard, and was exacerbated by the lack of availability...
Independent Panel for Pandemic Preparedness and Response: Uneven access to vaccination is pre-eminent problem
The Independent Panel for Pandemic Preparedness and Response (IPPPR) today released its findings in a report titled “Covid-19: Make it the last pandemic,” laying...
With technology transfer, 120 companies in low- and middle-income countries could manufacture mRNA vaccines
Recent reporting from the British Medical Journal (BMJ) has revealed efforts by BioNTech – the technology firm behind Pfizer’s projected $100 billion in Covid-19...
Gilead’s sofosbuvir patent in India – options for global access to new hepatitis C...
Earlier this month the US pharmaceutical company Gilead obtained a patent in India for sofosbuvir, part of a treatment of hepatitis C that became...
Ensuring that intellectual property rights aren’t a barrier to scaling-up: the remarkable example of...
This week various international bodies are tackling different challenges in meeting the urgent problem of scaling-up manufacture of and access to vaccines for Covid-19....
Never say never – Why the High Income Countries that opted-out from the Art....
To limit the ability of patent owners to charge excessive prices for patented medicines, countries can grant compulsory licences which permit others to produce...
Drug Price Transparency Calls Move from South Africa to World Health Assembly
by Katrina Perehudoff and Jennifer Sellin
Over 30 states and 40 business and civil society groups debated strategies for affordable and sustainable medicines prices at...